NASDAQ:AUPH

Aurinia Pharmaceuticals Stock Forecast

etoro logo Buy AUPH
*Your capital is at risk
$15.98
-0.0500 (-0.312%)
At Close: Jul 14, 2026
AI Analysis AI Analysis of AUPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AUPH to Watchlist?
Some Reasons Why To Add AUPH:
  • High gross margin of 89.7%
  • Strong operating margin of 41.7%
  • Strong return on equity of 64.5%
PDF

Red day on Tuesday for Aurinia Pharmaceuticals Inc
(Updated on Jul 14, 2026)

Buy or Hold candidate since Jul 07, 2026 Loss -1.48%

The Aurinia Pharmaceuticals Inc stock price fell by -0.312% on the last day (Tuesday, 14th Jul 2026) from $16.03 to $15.98. During the last trading day the stock fluctuated 2.33% from a day low at $15.85 to a day high of $16.22. The price has been going up and down for this period, and there has been a -4.82% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -476 thousand shares and in total, 824 thousand shares were bought and sold for approximately $13.16 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $15.57 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.37% during the next 3 months and, with a 90% probability hold a price between $16.25 and $19.61 at the end of this 3-month period.

AUPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 06, 2026, and so far it has risen 3.16%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aurinia Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $16.05 and $16.15. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Aurinia Pharmaceuticals Inc stock

Aurinia Pharmaceuticals Inc finds support from accumulated volume at $15.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.370 between high and low, or 2.33%. For the last week, the stock has had daily average volatility of 4.01%.

Our recommended stop-loss: $15.11 (-5.41%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (AUPH) For The Upcoming Trading Day Of Wednesday 15th

For the upcoming trading day on Wednesday, 15th we expect Aurinia Pharmaceuticals Inc to open at $16.02, and during the day (based on 14 day Average True Range), to move between $15.61 and $16.35, which gives a possible trading interval of +/-$0.746 (+/-4.78%) up or down from last closing price. If Aurinia Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 4.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $15.61 (2.32%) than the resistance at $16.37 (2.44%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aurinia Pharmaceuticals Inc stock A Buy?

Aurinia Pharmaceuticals Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.701 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 15, 2026 - $16.02 ( 0.229%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AUPH Performance

Trading levels for AUPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.39 2.54%
R2 16.25 1.66%
R1 16.16 1.11%
Price 15.98
S1 15.88 -0.655%
S2 15.79 -1.20%
S3 15.65 -2.09%

Accumulated Volume Support & Resistance Levels

Level Price
R3 18.62 16.52%
R2 17.23 7.82%
R1 16.37 2.44%
Price 15.98
S1 15.61 -2.32%
S2 15.54 -2.75%
S3 15.14 -5.26%

FAQ

What is the symbol for Aurinia Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Aurinia Pharmaceuticals Inc is AUPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aurinia Pharmaceuticals Inc Stock.

What's the current price of Aurinia Pharmaceuticals Inc Stock?
As of the end of day on the Jul 14, 2026, the price of an Aurinia Pharmaceuticals Inc (AUPH) share was $15.98.

What is the 52-week high and low for Aurinia Pharmaceuticals Inc Stock?
The 52-week high for Aurinia Pharmaceuticals Inc Stock is $19.25 and the 52-week low is $8.55.

What is the market capitalization of Aurinia Pharmaceuticals Inc Stock?
As of the Jul 14, 2026, the market capitalization of Aurinia Pharmaceuticals Inc is 2.055B.

When is the next earnings date for Aurinia Pharmaceuticals Inc?
The upcoming earnings date for Aurinia Pharmaceuticals Inc is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT AURINIA PHARMACEUTICALS INC
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada....
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
5.52% Jun 29
ROP
$331.60
4.54% Jun 24
JLL
$299.78
4.87% Jun 24
NESR
$25.07
16.83% Jun 23
CAG
$13.43
5.36% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE